This study systematically analyzed the expression profile and prognostic values of Arp2/3 complex members in HCC and found that ACTR3, ARPC2, and ARPC5 could be used as independent predictors of survival and might be applied as promising molecular targets for diagnosis and therapy of HCC in the future. This evidence concerns the gene ARPC2 and hepatocellular carcinoma.